Related Experiment Video
Updated: Dec 20, 2025

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
Published on: August 7, 2018
Beclin 1 functions as a negative modulator of MLKL oligomerisation by integrating into the necrosome complex
Jinho Seo1,2, Daehyeon Seong1, Young Woo Nam1
1Department of Biochemistry, College of Life science and Biotechnology, Yonsei University, Seoul, Korea.
Abstract:
Necroptosis is a form of regulated cell death caused by formation of the necrosome complex. However, the factors modulating this process and the systemic pathophysiological effects of necroptosis are yet to be understood. Here, we identified that Beclin 1 functions as an anti-necroptosis factor by being recruited into the necrosome complex upon treatment with TNFα, Smac mimetic, and pan-caspase inhibitor and by repressing MLKL oligomerisation, thus preventing the disruption of the plasma membrane. Cells ablated or knocked-out for Beclin 1 become sensitised to necroptosis in an autophagy-independent manner without affecting the necrosome formation itself. Interestingly, the recruitment of Beclin 1 into the necrosome complex is dependent on the activation and phosphorylation of MLKL. Biochemically, the coiled-coil domain (CCD) of Beclin 1 binds to the CCD of MLKL, which restrains the oligomerisation of phosphorylated MLKL. Finally, Beclin 1 depletion was found to promote necroptosis in leukaemia cells and enhance regression of xenografted-tumour upon treatment with Smac mimetics and caspase inhibitors. These results suggest that Beclin 1 functions as a negative regulator in the execution of necroptosis by suppressing MLKL oligomerisation.
Insights
Beclin 1 acts as a shield against necroptosis, a cell death pathway. It prevents cell membrane damage by inhibiting MLKL oligomerization, offering new therapeutic targets for diseases like leukemia.
Area of Science:
- Cell Biology
- Molecular Biology
- Immunology
Background:
- Necroptosis is a regulated cell death pathway crucial in immunity and disease.
- The molecular mechanisms and regulators of necroptosis are not fully understood.
- Identifying factors that control necroptosis is vital for therapeutic development.
Purpose of the Study:
- To investigate the role of Beclin 1 in regulating necroptosis.
- To elucidate the molecular mechanism by which Beclin 1 modulates necroptosis.
- To explore the therapeutic potential of targeting Beclin 1 in cancer.
Main Methods:
- Utilized cell-based assays to study necroptosis induction and regulation.
- Employed genetic manipulation (ablation and knockout) to assess Beclin 1 function.
- Performed biochemical analyses to determine molecular interactions between Beclin 1 and MLKL.
Main Results:
- Beclin 1 acts as an anti-necroptosis factor by inhibiting MLKL oligomerization.
- Beclin 1 is recruited to the necrosome complex in a MLKL-dependent manner.
- Beclin 1 depletion enhances necroptosis in leukemia cells and promotes tumor regression.
Conclusions:
- Beclin 1 is a novel negative regulator of necroptosis execution.
- Targeting Beclin 1 may offer a therapeutic strategy for cancers exhibiting necroptosis.
- Understanding Beclin 1's role provides insights into regulated cell death pathways.
More Related Videos
09:15Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells
Published on: October 20, 2022
13:02Production, Crystallization, and Structure Determination of the IKK-binding Domain of NEMO
Published on: December 28, 2019
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
The Intrinsic Apoptotic Pathway
Regulation of Nuclear Protein Sorting
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Negative Regulator Molecules